Aim: To examine and compare the predictive value of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), TC/HDL-C and LDL-C/HDL-C ratios for future cardiovascular outcomes in the general Japanese population. Methods: A total of 24,566 eligible participants aged 18 years or older, without cardiovascular disease, were enrolled through multiphase health screening and divided into quartile groups based on lipoprotein levels or ratios. Primary endpoints of the study were definitive acute myocardial infarction (AMI) and ischemic stroke, and cases of sudden death with unknown causes were not included. We used Cox proportional hazard models to examine the relationships between the quartiles and incidences of AMI or ischemic stroke, adjusting for traditional risk factors. Results: Mean age was 63.7 years for males and 60.7 years for females. Mean follow-up period was 2.7 years, and 40 cases of AMI and 182 cases of ischemic stroke were recorded. The hazard ratio (HR) for AMI was significantly higher in the top quartile of the LDL-C/HDL-C ratio and LDL-C levels, and third quartile of TC among male participants. The HR of male participants with a LDL-C/HDL-C ratio of 2.6 or higher was significantly higher than other quartiles. No association between lipoprotein levels or their ratio quartiles and ischemic stroke was seen for either sex after adjusting for risk factors. Conclusions: Our results indicated that the LDL-C/HDL-C ratio is an independent predictor for AMI, and the importance of better management of cardiovascular risks among people with high LDLC/HDLC ratios for the prevention of future cardiovascular disease. J Atheroscler Thromb, 2011; 18:89-98.
Introduction
According to the World Health Organization, cardiovascular disease was the most common cause of death worldwide in 2005, accounting for approximately 30% of all deaths 1) . Among individuals 60 years of age or older, the main cause of death was isch-emic heart disease, followed by cerebrovascular disease 2) . Prevention of cardiovascular disease (CVD), which includes cardiovascular and cerebrovascular disorders, is emphasized in both developed and developing countries 1, 2) . Dyslipidemia is an independent risk factor that contributes to the increase of CVD and death 3, 4) . Epidemiological studies 5, 6) have conclusively linked high levels of low-density lipoprotein cholesterol (LDL-C) and low levels of high-density lipoprotein cholesterol (HDL-C) with CVD incidence and mortality. The positive association between the LDL-C level and risk has been confirmed in a lipid-lowering randomized trial 7) . Current guidelines for the prevention of atherosclerotic disorders recommend specific target levels of lipid profiles to determine CVD risk and to evaluate the effectiveness of lipid-lowering therapies 8, 9) . Accordingly, LDL-C and HDL-C measurements are included in the standard health check-up supported by the Japanese government.
In recent years, additional indicators of CVD based on standard serum lipid profiles have been introduced 5, 10) . For instance, the total cholesterol (TC)/ HDLC ratio is a useful and simple index of CVD risk 11) . Furthermore, the LDL-C/HDL-C ratio more accurately predicts CVD risk than LDL-C or HDL-C levels 5, 12) . In a large-scale intervention trial, a change in this ratio was a better indicator of successful CVD risk reduction 13) . Although previous studies have investigated the association between levels and the ratios of various lipoproteins and CVD risk 10, [12] [13] [14] , only a few reports have evaluated the clinical utility of various lipid measures to predict CVD in Japan.
The aims of our study were to examine and compare the relationships between levels of TC, HDL-C, LDL-C, ratios of TC/HDL-C and LDL-C/HDL-C, and future cardiovascular outcomes among rural Japanese residents.
Methods

Study Participants
This study was part of the large population-based prospective Iwate Kenpoku Cohort study (Iwate-KENCO study) and a government-sponsored, multiphase health check-up program in the northern part of the Japanese main island. Survey methods have been described in detail previously 15, 16) . The baseline survey was conducted from April 2002 to January 2005. Participants were recruited from the community-dwelling population living in the Ninohe, Kuji and Miyako districts of Iwate prefecture, which include 17 municipalities. During the survey period, individuals in these municipalities were invited to participate in multiphase health screening. A total of 31,318 residents (11,003 males and 20,315 females) aged 18 years or older participated in the annual health check-up. We obtained written informed consent from 26,469 of these residents. After excluding 1,903 participants due to a self-reported history of CVD, medical history of CVD confirmed by the Northern Iwate Heart Disease Registry Consortium (NIHDRC) database and the Iwate Stroke Registry (ISR) database 17) , taking lipid-lowering medications, and missing data for lipid-related items, we included 24,566 (8,714 males and 15,852 females) in the present analysis.
The study was approved by the Medical Ethics Committee of Iwate Medical University and conducted in accordance with the Declaration of Helsinki 18) .
Measurements
We measured height and weight, and calculated body mass index (BMI) using the following equation: BMI body weight (kg)/height (m) 2 . Blood pressure was measured twice in a sitting position after urination and a five-minute rest. Measurements were performed by well-trained staff using automatic devices, and the average of the two measurements was reported for systolic and diastolic blood pressures (SBP and DBP).
Self-administered questionnaires were used in the baseline survey to obtain demographic characteristics, history of cardiovascular disease, cerebrovascular disease, medication use, alcohol consumption, tobacco smoking and exercise habits.
Biochemical Analysis
Fasting or casual blood samples were collected from the antecubital vein, transferred to a laboratory and analyzed the same day. Serum total cholesterol (TC), triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C) levels were measured by enzymatic methods. Serum low-density lipoprotein cholesterol (LDL-C) was measured by the enzymatic homogenous assay, Cholestest-LDL (Daiichi Chemicals Co. Ltd, Tokyo, Japan). These lipid profiles were measured by Iwate Health Service Association. These measurements have been standardized by the Osaka Medical Center for Health Science and Promotion, a member of the Cholesterol Reference Method Laboratory Network (CRMLN) controlled by the CDC (Centers for Disease Control and Prevention, Atlanta, USA), and have met all criteria for both the precision and accuracy of lipid measurements.
We measured plasma glucose concentrations by the hexokinase ultraviolet method using an automated analyzer (Hitachi High-Technologies Corporation, Tokyo, Japan). Glycosylated hemoglobin A1c (HbA1c) levels were determined by high-performance liquid chromatography using an automated analyzer (Tosoh Corporation, Tokyo, Japan).
We determined serum levels of high-sensitivity C-reactive protein (hs-CRP) using the latex-enhanced immunonephelometric method (Dade Behring, Germany). The detection limit of the hs-CRP assay is 0.1 mg/L and results below the limit of detection were reported as 0.1 mg/L.
Outcome Measures
The primary endpoints of this study were the incidence of definitive acute myocardial infarction (AMI) or ischemic stroke, while cases of sudden death of unknown cause were not included as cardiovascular endpoints. Investigators reviewed the population register of each local government and confirmed dates of death and locations to which participants had relocated. Persons known to be alive at the end of follow-up and those who had moved away from the study areas were treated as censored cases 16) . We confirmed that approximately 99.9% of participants who were registered at the baseline were alive. Incidences of AMI among participants were confirmed by assessing the Northern Iwate Heart Disease Registry Consortium (NIHDRC) database, in which definitive AMI cases were determined based on the criteria of the MONICA study. Incidences of ischemic stroke were confirmed by accessing the Iwate Stroke Registry (ISR) database 17) .
Statistical Analysis
For each sex, we determined the prevalence (for categorical variables) and mean and standard deviation (for continuous variables). Participants were categorized as follows: LDL-C/HDL-C ratio quartiles (Q1 1.6, Q2 ≥ 1.6 -2.1, Q3 ≥ 2.1 -2.6, Q4 ≥ 2.6), TC level (mg/dL) quartiles (Q1 180, Q2 ≥ 180 -200, Q3 ≥ 200 -220, Q4 ≥ 220), LDL-C level (mg/dL) quartiles (Q1 100, Q2 ≥ 100 -120, Q3 ≥ 120 -140, Q4 ≥ 140), HDL-C level (mg/dL) quartiles (Q1 50, Q2 ≥ 50 -60, Q3 ≥ 60 -70, Q4 ≥ 70) and TC/HDL-C ratio quartiles (Q1 2.8, Q2 ≥ 2.8 -3.4, Q3 ≥ 3.4 -4.1, Q4 ≥ 4.1). Significance was estimated using the Kruskal-Wallis test for continuous items and the Chi-square test or Fisher's exact test for categorical items among quartiles.
Disease-free survival curves for AMI or ischemic stroke cases based on lipid profiles and their ratio quartiles were determined using Kaplan-Meier methods. Age-and multivariate-adjusted hazard ratios (HR) and 95% confidence intervals (CI) were computed using Cox proportional hazard models. To estimate adjusted HR, we included age (10 years increase), current smoking status (yes or no), SBP, BMI, uric acid and HbA1c in the multivariate adjusted models from our previous report 15) . All significance tests were two-sided and p values 0.05 were considered significant. All data were analyzed using SPSS version 16 (SPSS Inc., Chicago, USA). Table 1 shows the characteristics of study participants. Mean age was 63.7 years for males and 60.7 years for females. The proportions of hypertension were 26.0% for males and 24.4% for females, and 7.0% and 3.5% for diabetes mellitus. Mean follow-up period was 2.7 years. During the survey period, 35 males and 5 females suffered from AMI, and 114 males and 68 females suffered from ischemic stroke. We could not estimate a survival curve for AMI for females due to its low incidence.
Results
The LDL-C/HDL-C ratio-specific characteristics at baseline among male participants are shown in Table 2 . BMI, HbA1c, uric acid, TC, TG, LDL-C and hs-CRP were significantly correlated with higher LDL-C/HDL-C ratio quartiles. In contrast, the proportion of participants who regularly consumed alcohol and HDL-C seemed to be inversely correlated with LDL-C/HDL-C ratio quartiles. Fig. 1 shows disease-free survival curves for AMI among males based on LDL-C/HDL-C ratio quartiles. The disease-free survival rate for male participants with a LDL-C/HDL-C ratio of 2.6 or higher (fourth quartile) was significantly different from other quartiles. Multivariate-adjusted HR of Q4 was significantly higher than Q1 (p 0.03) ( Table 3-1) .
Multivariate-adjusted HR of Q3 for TC levels (HR 2.44, p 0.04) and Q4 for LDL-C levels (HR 2.50, p 0.04) were significantly higher and that of Q3 for HDL-C levels (HR 0.20, p 0.03) was significantly lower than Q1; however, a linear and obvious relationship was not observed across all quartiles ( Table 3-1) . Table 3 -2 shows hazard ratios for ischemic stroke based on lipoprotein levels and their ratio quartiles among males. For the LDL-C/HDL-C ratio, no significant relationship was found between quartiles and the risk of ischemic stroke [multivariate-adjusted HR of Q4 0.86 (p 0.56)]. Furthermore, no relationship was found between quartiles of LDL-C levels, HDL-C levels and the TC/HDL-C ratio, and the risk of ischemic stroke [multivariate-adjusted HRs of Q4 0.73 (p 0.27) for LDL-C levels, 0.90 (p 0.73) for HDL-C levels and 0.81 (p 0.47) for TC/HDL-C ratio]. Although multivariate-adjusted HR of Q3 for TC levels was significantly lower than Q1 (HR 0.55, p 0.04), a linear and obvious relationship was not observed across quartiles. Table 3 -3 shows hazard ratios for ischemic stroke for lipoprotein levels or their ratio quartiles among females. We found no significant relationship between quartiles of LDL-C/HDL-C ratio and risk of ischemic stroke [multivariate-adjusted HR of Q4 1.17 (p 0.69)]. In addition, we observed no relationship between the other quartiles [multivariate-adjusted Table 2 . LDL-C/HDL-C ratio-specific characteristics among male participants at baseline (n 24566) LDL-C/HDL-C ratio N (%) or mean (SD) 
Discussion
This community-based, prospective cohort study conducted in a Japanese rural area showed that the LDL-C/HDL-C ratio at baseline was an independent predictor for future AMI among male participants, with a ratio of 2.6 or higher suggesting a risk of disease. Although an association between LDL-C and TC quartiles and the risk was observed, it may be weaker than LDL-C/HDL-C. On the other hand, we observed no obvious association between any lipoprotein level or their ratio quartiles and the risk of ischemic stroke in either sex. To the best of our knowledge, this is the first report to prospectively examine the association between the lipoprotein level or ratio quartiles and cardiovascular events, and to clarify the relationship between the LDL-C/HDL-C ratio and AMI among males in a rural Japanese community.
Several epidemiological studies have reported the LDL-C/HDL-C ratio to be an excellent predictor of coronary heart disease (CHD) risk 10, [12] [13] [14] 19) . In the Helsinki Heart Study 12) , the LDL-C/HDL-C ratio was a strong predictor of CHD risk among participants with high triglyceride levels during 5-year follow up. Furthermore, the PROSPER study 13) , which was a prospective cohort study that examined about 5,800 elderly participants over 3.7 years, suggested that increased CHD risk is associated with an elevated LDL-C/HDL-C ratio. In contrast, the Quebec Cardiovascular Study 11) showed that ratios of LDL-C/ HDL-C and TC/HDL-C were associated with ischemic heart disease, and indicated that the TC/HDL-C LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TC, total cholesterol a Unadjusted incidence rate per 1,000,000 per year. b Age (10-year increase), current smoking, systolic blood pressure, body mass index, uric acid, and hemoglobin A1c were included in the Cox regression analysis. ratio might be a better indicator than the LDL-C/ HDL-C ratio in males; however, a population-based cohort study from Framingham, Massachusetts reported that ratios of TC/HDL-C and LDL-C/ HDL-C were positively associated with coronary heart disease risk in both sexes 5) . In the present study, multivariate-adjusted analysis showed that while the incidence of AMI was significantly associated with the LDL-C/HDL-C ratio, the magnitude of HR was almost identical in each quartile group of LDL-C/ HDL-C and TC/HDL-C. Long-term observation may be needed to reveal an association between the LDL-C/HDL-C ratio or TC/HDL-C ratio and risk of future cardiovascular events.
We also observed a positive association between LDL-C levels and AMI. LDL-C is well known as an important risk factor for CVD. In the Suita study 20) , which analyzed about 4,700 participants over a 11.9 years, the risk of myocardial infarction in the highest quartile of LDL-C (≥ 3.91 mmol/L) was 3.73 times higher than in the lowest quartile ( 2.54 mmol/L) in males. Likewise, we showed that the highest quartile of LDL-C was significantly associated with the incidence of AMI. Upon additional analysis, no significant association was found between the LDL-C/ HDL-C ratio and AMI after stratifying with the LDL-C median level [multivariate-adjusted HR of Q4 in high LDL-C 3.00 (p 0.56) and in low LDL-C 0.70 (p 0.66)]. The predictive value of LDL-C/ HDL-C for AMI incidence may be evident with relatively high serum LDL-C (≥ 120 mg/L); however, LDL-C quartiles did not show a clear and linear trend compared to the LDL-C/HDL-C ratio. Moreover, TC quartiles did not show a liner a association in this study, although the third quartile of TC levels was significantly associated with the incidence; therefore, the LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TC, total cholesterol a Unadjusted incidence rate per 1,000,000 per year. b Age (10-year increase), current smoking, systolic blood pressure, body mass index, uric acid, and hemoglobin A1c were included in the Cox regression analysis.
LDL-C/HDL-C ratio may have greater clinical potential as a predictor of AMI than LDL-C or TC levels.
HDL-C is a well-known protective factor against CVD, and its levels are inversely associated with CHD 21) . We did not observe a clear association in the present study, which may have been due to the shorter follow-up period. Nevertheless, the LDL-C/HDL-C ratio at baseline was independently associated with future AMI, suggesting that the LDL-C/HDL-C ratio may better predict the outcome than HDL-C alone.
Interestingly, our results showed that the hazard ratio in male participants with a LDL-C/HDL-C ratio of 2.6 or higher was significantly higher than other quartiles. The Munster Heart Study (PROCAM) 14) , which included middle-aged German men, showed a continuous and graded relationship between the LDL-C/HDL-C ratio and CHD mortality, with an increase in CHD deaths when the ratio was between 3.7 and 4.3. A clinical study of Japanese patients with suspected ischemic coronary disease evaluated the relationship between plaque formation and lipoprotein levels in coronary arteries using intravascular ultrasonography and found that the mean plaque area was significantly higher if the LDL-C/HDL-C ratio was at least 2.5 22) . It is possible that a LDL-C/HDL-C ratio of 2.6 or higher is a risk factor for AMI among Japanese males, and our results suggest that it is important to maintain an LDL-C/HDL-C ratio lower than 2.6 for primary prevention of AMI.
We did not find an association between the LDL-C/HDL-C ratio and ischemic stroke. Furthermore, there were mostly non-significant associations between other lipid profiles or their indices and ischemic stroke. The Cardiovascular Health study 23) reported a positive association between LDL-C and the risk of ischemic stroke, and the Oyabe study 24) demonstrated an inverse relationship between HDL-C levels and ischemic stroke incidence; however, the Framingham study 25) and Hisayama study 26) did not report a clear association between the LDL-C level and the risk of ischemic stroke, and HDL-C levels were not associated with the risk of ischemic stroke in the Women's Health study 27) . Furthermore, LDL-C and HDL-C were not associated with ischemic stroke in the Atherosclerosis Risk in Community study 28) . Also, the NIPPON DATA 80 29, 30) reported that there was no relationship between ischemic stroke and TC levels. We propose three possible explanations for these discrepancies. First, these associations were heterogeneous across ischemic stroke subtypes, and lacunar infarction and cardioembolic infarction seem to be less associated with elevated LDL-C levels than atherothrombotic infarction 26) . It is probable that including these subtypes in the analysis masks the true association; therefore, the LDL-C/HDL-C ratio may not be clearly associated with the risk of total ischemic stroke in the present study. Ischemic stroke subtypespecific analysis may be needed to assess the potential relationship with the LDL-C/HDL-C ratio. Second, the follow-up period in our study was relatively short compared to previous studies. Long-term observation may reveal an association between the LDL-C/HDL-C ratio and risk of ischemic stroke. Finally, adjustment for confounding factors, especially blood pressure levels, might be insufficient in multivariate analysis. Ischemic stroke is likely to be influenced by blood pressure levels compared to AMI, and insufficient adjustment for blood pressure levels may mask the true association. To improve the accuracy of our findings, additional analysis stratified by blood pressure levels may be needed.
We found that the LDL-C/HDL-C ratio was associated with cardiovascular risk factors in both sexes. The Hisayama study 26) reported that LDL-C levels were linearly correlated with BMI, fasting blood glucose levels, and systolic and diastolic blood pressures, while HDL-C levels were inversely correlated with LDL-C levels. These factors are components of metabolic syndrome (MetS), which has received considerable attention because it is known to be a condition associated with a high risk for ischemic heart disease 31) . Furthermore, the LDL-C/HDL-C ratio was significantly correlated with hs-CRP levels, which is a circulatory inflammatory marker and well-known predictor of atherosclerotic disorders 32) ; therefore, it is probable that the LDL-C/HDL-C ratio can assess the inflammation of blood vessels.
Our study has several limitations. The first is selection bias. Participants were selected from those who attended the annual health check-up, and they may have greater health awareness than the general population. Second, the follow-up period was relatively short (2.7 years) compared to previous cohort studies that observed outcomes for more than five years. Long-term observational studies may be needed to access causal associations between the LDL-C/ HDL-C ratio and cardiovascular outcomes. Third, unknown sudden deaths were excluded from analysis, and it is possible that incidences were underestimated. Fourth, the present study investigated the outcome of total ischemic stroke. Ischemic stroke subtype-specific analysis may be needed in the future. Finally, we used LDL-C levels directly measured by a homogeneous assay in this study. It is possible that directly measured LDL-C levels are not as accurate as calculated LDL-C levels.
Conclusions
The LDL-C/HDL-C ratio at baseline was an independent predictor of future AMI among Japanese males. A ratio of 2.6 or higher may indicate non-fatal AMI risk, and might have the potential to assess the inflammation of blood vessels. In addition to other lipid profiles and ratios, our results indicate the utility of the LDL-C/HDL-C ratio as a predictor of AMI among men and the importance of lifestyle modification and better management of cardiovascular risks among people with high LDLC/HDLC ratios for primary prevention of future cardiovascular disease; however, given the relatively short follow-up period of this study, long-term studies may be needed to confirm our findings.
